ArticleOncoimmunology2016

PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.

Chang-Long Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.